197 related articles for article (PubMed ID: 16637863)
1. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
Muir AJ; Sylvestre PB; Rockey DC
J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of interferon gamma for chronic hepatitis C.
Soza A; Heller T; Ghany M; Lutchman G; Jake Liang T; Germain J; Hsu HH; Park Y; Hoofnagle JH
J Hepatol; 2005 Jul; 43(1):67-71. PubMed ID: 15913831
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
4. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
Pockros PJ; Jeffers L; Afdhal N; Goodman ZD; Nelson D; Gish RG; Reddy KR; Reindollar R; Rodriguez-Torres M; Sullivan S; Blatt LM; Faris-Young S
Hepatology; 2007 Mar; 45(3):569-78. PubMed ID: 17326152
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
6. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
8. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.
Nevens F; Roskams T; Van Vlierberghe H; Horsmans Y; Sprengers D; Elewaut A; Desmet V; Leroux-Roels G; Quinaux E; Depla E; Dincq S; Vander Stichele C; Maertens G; Hulstaert F
Hepatology; 2003 Nov; 38(5):1289-96. PubMed ID: 14578869
[TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus].
Gonzalez-Huezo MS; Gallegos-Orozco JF
Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938
[TBL] [Abstract][Full Text] [Related]
11. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.
McHutchison J; Goodman Z; Patel K; Makhlouf H; Rodriguez-Torres M; Shiffman M; Rockey D; Husa P; Chuang WL; Levine R; Jonas M; Theodore D; Brigandi R; Webster A; Schultz M; Watson H; Stancil B; Gardner S;
Gastroenterology; 2010 Apr; 138(4):1365-73, 1373.e1-2. PubMed ID: 20004661
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
13. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
14. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
15. A novel treatment of patients with chronic hepatitis C.
Tsai NC; Shimoda N; Wong L; Shimoda S; Goad K; Yee H; Chen M
Hawaii Med J; 1999 Apr; 58(4):85-8. PubMed ID: 10363429
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
[TBL] [Abstract][Full Text] [Related]
18. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
Yu ML; Lin SM; Lee CM; Dai CY; Chang WY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Liaw YF
Hepatology; 2006 Nov; 44(5):1086-97. PubMed ID: 17058238
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
[TBL] [Abstract][Full Text] [Related]
20. Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches.
Musch E; Malek M; von Eick H; Chrissafidou A
Hepatogastroenterology; 2004; 51(59):1476-9. PubMed ID: 15362781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
